Ionis Pharmaceuticals | IONS - Vermögenswerte

Aktienkurs
73.27
Täglich Wechseln
-0.82 -1.11%
Monatlich
0.78%
Jährlich
146.70%
Q2 Prognose
71.70




Vermögenswerte Veränderung Datum
Agios Pharmaceuticals USD 1.3B 88.48M 2025-12
Alnylam Pharmaceuticals USD 4.97B 114.67M 2025-12
Arrowhead Research USD 1.6B 218.89M 2025-12
Astellas Pharma JPY 3.6T 153.62B 2025-12
BioCryst Pharmaceuticals USD 514.16M 67.73M 2025-12
BioMarin Pharmaceutical USD 7.59B 20.85M 2025-12
Celltrion KRW 21.08T 530.63B 2025-09
Cspc Pharmaceutical CNY 46.7B 695.56M 2025-12
Deva Holding AS TRY 12.93B 1.83B 2023-09
Divis Laboratories Ltd INR 181.51B 12.19B 2025-09
Esperion Therapeutics USD 465.89M 101.87M 2025-12
Exelixis USD 2.84B 20.87M 2025-12
Halozyme Therapeutics USD 2.53B 304.09M 2025-12
Ionis Pharmaceuticals USD 3.52B 490.91M 2025-12
Kangmei Pharma CNY 13.68B 38.19M 2025-09
Knight Therapeutics CAD 1.05B 2.28M 2025-12
Laboratorios Farma EUR 799.88M 99.95M 2023-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Moderna USD 12.34B 203M 2025-12
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Neurocrine Biosciences USD 4.63B 365.8M 2025-12
Novartis USD 110.95B 3.66B 2025-12
Omeros USD 200.57M 34.59M 2025-06
OPKO Health USD 1.93B 63.57M 2025-12
Organigram Holdings CAD 530.67M 31.54M 2025-12
Ovoca Bio EUR 1.66M 9.75M 2025-06
Pfizer USD 208.73B 2.64B 2025-09
Pharma Mar EUR 395.08M 53.42M 2025-12
PTC Therapeutics USD 2.9B 255.07M 2025-12
Qiagen NV USD 6.3B 257.54M 2025-12
Regeneron Pharmaceuticals USD 40.56B 389.3M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Sarepta Therapeutics USD 3.35B 143.73M 2025-12
Sartorius EUR 9.87B 154.9M 2026-03
Sino Biopharmaceutical CNY 74.89B 9.49B 2025-06
Tilray USD 2.1B 15.95M 2025-09
Ultragenyx Pharmaceutical USD 1.53B 341.56M 2025-12
Vertex Pharmaceuticals USD 25.64B 780.7M 2025-12
Zealand Pharma A/S 15.95B 848.45M 2025-12
Zz Pientze Pharmaceu CNY 17.48B 1.23B 2025-09